Skip to content

Clinical trials

Phase 2/3 trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Austria Clear all

149 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20021
20044
20056
20068
20077
20088
20095
20107
20115
20126
20135
20145
20151
20166
20174
201811
20194
20206
20217
20225
20235
20248
202510
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Recruiting24
Terminated21
Unknown status17
Active, not recruiting11
Enrolling by invitation2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical University of Vienna16
Pfizer7
Bristol-Myers Squibb6
Boehringer Ingelheim5
Novartis Pharmaceuticals5
AbbVie4
Janssen Research & Development, LLC4
Baxalta now part of Shire3
CSL Behring3
Celgene3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative8
Heart Failure5
Neoplasm Metastasis5
Neoplasms5
Breast Neoplasms4
Head and Neck Neoplasms4
Hemophilia A4
Squamous Cell Carcinoma of Head and Neck4
COVID-193
Carcinoma, Non-Small-Cell Lung3

Trials

Showing 51 to 75 of 149. Each trial links to its page on Pharma Observatory.

49 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.